We are delighted to announce that Dr. Rita Balice-Gordon and Dr. Phil Skolnick have joined PAASP’s Advisory Board:
Rita Balice-Gordon, Ph.D., is the Global Head, Rare and Neurologic Diseases Research Therapeutic Area at Sanofi, Inc. Rita was formerly Vice-President and Head of Circuits, Neurotransmitters and Signaling in Pfizer’s Neuroscience and Pain Research Unit, and was Head of the Worldwide Research and Development Postdoctoral Program there. Prior to joining Pfizer, Rita was Professor of Neuroscience and Chair of the Neuroscience Graduate Group in the Perelman School of Medicine at the University of Pennsylvania, where she currently holds an appointment as Adjunct Professor.

Dr. Phil Skolnick is the Chief Scientific Officer at Opiant Pharmaceuticals, Inc. Prior to joining Opiant, Phil was the Director, Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse, NIH (2010-2017). Phil served as Chief Scientific Officer (2001-2009) and President (2007-2009) of DOV Pharmaceutical, Inc.

PAASP’s Advisory Board includes renowned leaders in the field of Good Research Practice and Scientific Integrity representing academia, industry and non-profit organizations. Read more about our Advisory Board members HERE.